This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masarachia, P. Articles by Duong, L. Search for Related Content PubMed PubMed Citation Articles by Masarachia, P. Articles by Duong, L.

Histomorphometric Evidence for Echistatin Inhibition of Bone Resorption in Mice with Secondary Hyperparathyroidism

Department of Bone Biology and Osteoporosis Research, Merck Research Laboratories, West Point, Pennsylvania 19486

Address all correspondence and requests for reprints to: Patricia Masarachia, Department of Bone Biology and Osteoporosis Research, Merck Research Laboratories, Sumneytown Pike, West Point, Pennsylvania 19486. E-mail: patricia_masarachia{at}merck.com

Echistatin, an RGD-containing peptide, was shown to inhibit the acute calcemic response to exogenous PTH or PTH-related protein (PTH-rP) in thyroparathyroidectomized rats, suggesting that echistatin inhibits bone resorption. In this study: 1) we present histological evidence for echistatin inhibition of bone resorption in mice with secondary hyperparathyroidism, and show that 2) echistatin binds to osteoclasts in vivo, 3) increases osteoclast number, and 4) does not detectably alter osteoclast morphology. Infusion of echistatin (30 µg/kg·min) for 3 days prevented the 2.6-fold increase in tibial cancellous bone turnover and the 36% loss in bone volume, produced by a low calcium diet. At the light microscopy level, echistatin immunolocalized to osteoclasts and megakaryocytes. Echistatin treatment increased osteoclast-covered bone surface by about 50%. At the ultrastructural level, these osteoclasts appeared normal, and the fraction of cells containing ruffled borders and clear zones was similar to controls. Echistatin was found on the basolateral membrane and in intracellular vesicles of actively resorbing osteoclasts. Weak labeling was found in the ruffled border, and no immunoreactivity was detected at the clear zone/bone surface interface. These findings provide histological evidence for echistatin binding to osteoclasts and for inhibition of bone resorption in vivo, through reduced osteoclast efficacy, without apparent changes in osteoclast morphology.

This article has been cited by other articles:

				S. R. Wilson, C. Peters, P. Saftig, and D. Bromme Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption J. Biol. Chem., January 23, 2009; 284(4): 2584 - 2592. [Abstract] [Full Text] [PDF]

				C. A. O'Brien, R. L. Jilka, Q. Fu, S. Stewart, R. S. Weinstein, and S. C. Manolagas IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E784 - E793. [Abstract] [Full Text] [PDF]

				C. Dolce, A. Vakani, L. Archer, J.A. Morris-Wiman, and L.S. Holliday Effects of Echistatin and an RGD Peptide on Orthodontic Tooth Movement Journal of Dental Research, September 1, 2003; 82(9): 682 - 686. [Abstract] [Full Text] [PDF]

				H. Vaananen, H Zhao, M Mulari, and J. Halleen The cell biology of osteoclast function J. Cell Sci., January 2, 2000; 113(3): 377 - 381. [Abstract] [PDF]

				I Nakamura, M. Pilkington, P. Lakkakorpi, L Lipfert, S. Sims, S. Dixon, G. Rodan, and L. Duong Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone J. Cell Sci., January 11, 1999; 112(22): 3985 - 3993. [Abstract] [PDF]

				I. Nakamura, H. Tanaka, G. A. Rodan, and L. T. Duong Echistatin Inhibits the Migration of Murine Prefusion Osteoclasts and the Formation of Multinucleated Osteoclast-Like Cells Endocrinology, December 1, 1998; 139(12): 5182 - 5193. [Abstract] [Full Text] [PDF]

				M. Yamamoto, J. E. Fisher, M. Gentile, J. G. Seedor, C.-T. Leu, S. B. Rodan, and G. A. Rodan The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats Endocrinology, March 1, 1998; 139(3): 1411 - 1419. [Abstract] [Full Text] [PDF]

				L. T. Duong, I. Nakamura, P. T. Lakkakorpi, L. Lipfert, A. J. Bett, and G. A. Rodan Inhibition of Osteoclast Function by Adenovirus Expressing Antisense Protein-tyrosine Kinase 2 J. Biol. Chem., March 2, 2001; 276(10): 7484 - 7492. [Abstract] [Full Text] [PDF]